Literature DB >> 6986629

Serotherapy of malignant disease.

P W Wright, I D Bernstein.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6986629

Source DB:  PubMed          Journal:  Prog Exp Tumor Res        ISSN： 0079-6263


× No keyword cloud information.
  3 in total

1.  Antibody-dependent cellular cytotoxicity-mediated serotherapy against murine neuroblastoma. I. In vitro and in vivo treatment using normal, gamma-irradiated and immune-stimulated rat effector cells.

Authors:  J E Byfield; R Zerubavel; E W Fonkalsrud
Journal:  Cancer Immunol Immunother       Date:  1982       Impact factor: 6.968

2.  Serotherapy of L1210 murine leukaemia--reasons for ineffectiveness of in vivo treatment by L.1 monoclonal antibody.

Authors:  C Testorelli; G Canti; P Franco; A Goldin; A Nicolin
Journal:  Br J Cancer       Date:  1983-03       Impact factor: 7.640

3.  Therapy of murine leukemia with monoclonal antibody against a normal differentiation antigen.

Authors:  C C Badger; I D Bernstein
Journal:  J Exp Med       Date:  1983-03-01       Impact factor: 14.307
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.